Big Health Digital Therapeutics Rings In 2022 With $75M Financing, FDA Alum On Board
Executive Summary
Big Health will use its $75m in new funding to scale the business, with plans to launch six new digital therapeutics by 2024. Former US FDA official Anand Shah will join its board of directors.
You may also be interested in...
CVS Health CMO Troyen Brennan Finds Digital Health Evidence 'Often Thin’
CVS Health chief medical officer Troyen Brennan discussed his outlook on digital health – which he said “still feels a little young” – and his views on the future of health care, pharmacies, and primary care at the DHIS West conference.
Playing Big: Akili To Be Bought By Chamath Palihapitiya’s SPAC In $1Bn Deal
Akili Interactive, which developed a video game to treat ADHD, will go public with one of Palihapitiya’s blank-check companies. The proceeds will be used to launch the FDA-cleared EndeavorRx digital therapeutics.
Pear CEO Sees Fulfilment And Reimbursement Challenges Ahead
Medtech Insight spoke to Pear Therapeutics CEO Corey McMann about the emerging digital therapeutics market and his company’s future now that it has the first PDT covered by Medicaid.